In this study, we found that TGFβRI expression exhibited an inverse correlation with disease activity in SLE patients and that IL-6 triggered JAK/STAT3 pathway was involved in the downregulation of TGFβRI. The gene discussed is STAT3; the disease is systemic lupus erythematosus.